Marina Lubimova
He also joined the company's Audit Committee and the board of Citibank, N.A., according to an SEC filing.
Appointment Details
| Parameter | Details |
| Company | Citigroup Inc. |
| Ticker | NYSE: C |
| Director | James Flanagan |
| Effective date | October 21, 2026 |
| Position | Independent Director |
| Committee | Audit Committee |
| Additional role | Citibank, N.A. Director |
| Previous employer | PwC |
| Previous senior positions | COO and Vice Chairman (2014–2021) |
Citigroup Stock Performance
Citigroup shares closed at $122.51 on October 22, 2026, down $1.34 (1.08%).
The daily chart shows a decline from approximately $145 to $122.51, equivalent to roughly 15.5%.
Intraday Price Movement
On October 22, the displayed trading period showed a decline from above $123 to approximately $121, followed by a recovery toward $122.50.
The post-market quote of $122.78 was approximately 0.22% above the regular-session closing price.
No direct connection between these price movements and Flanagan's appointment has been established.
Flanagan's Background
Flanagan spent nearly 40 years at PricewaterhouseCoopers (PwC), including serving as Chief Operating Officer and Vice Chairman from 2014 to 2021.
He is a Certified Public Accountant and previously served as Audit Committee Chair at Belami Ecommerce.
Previous vs. New Board Structure
| Category | Before appointment | After appointment |
| Flanagan's status | Not a director | Independent director |
| Audit Committee | Six members listed in March 2026 proxy | Flanagan appointed |
| Citibank, N.A. board | No Flanagan membership disclosed | Flanagan appointed |
| Audit Committee Chair | James S. Turley | No announced change |
| External auditor | KPMG LLP | No announced change |
Jim's deep experience across risk, operations, technology and accounting will bring valuable perspective to our Board. Citigroup CEO Jane Fraser commented
Conclusion
Flanagan's appointment adds accounting, audit and operational leadership experience to Citigroup's board.
Citigroup shares closed at $122.51 on October 22, down 1.08%. The appointment's financial impact has not been established.
Marina Lubimova
